Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Last updated: 2020
Remove filter for
Type: Alert
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
- (-) 2020
- December 20209 results available
- November 20201 results available
- October 20209 results available
- September 20206 results available
- August 20201 results available
- July 20204 results available
- June 20203 results available
- May 20207 results available
- April 20207 results available
- March 20203 results available
Displaying 1 - 15 of 50 items.
GUM Paroex (anti-gingivitis oral rinse) being recalled due to microbial contamination that could lead to respiratory and other infections in patients
GUM Paroex (anti-gingivitis oral rinse) being recalled due to microbial contamination that could lead to respiratory and other infections in patients…
AlertPublic advisory | 2020-12-24
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
Authorization of Moderna COVID-19 Vaccine with English-only Vial and Carton Labels
Starting date:
December 23, 2020…
AlertHealth professional risk communication | 2020-12-23
Personal protective equipment sold by Maskopia (formerly Medkem Canada Inc.) may pose serious health risks
Personal protective equipment sold by Maskopia (formerly Medkem Canada Inc.) may pose serious health risks
Starting date…
AlertPublic advisory | 2020-12-22
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
Bacitracin for Injection (50,000 IU per vial) and the Risk of Nephrotoxicity and Anaphylactic Reactions
Starting date:…
AlertHealth professional risk communication | 2020-12-21
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Authorization of Bamlanivimab with English-only Labels for Use in Relation to the COVID-19 Pandemic
Starting date:…
AlertHealth professional risk communication | 2020-12-18
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
ELMIRON (pentosan polysulfate sodium) and the Risk of Pigmentary Maculopathy
Starting date:
December 15, 2020…
AlertHealth professional risk communication | 2020-12-15
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
Starting date:
December…
AlertPublic advisory | 2020-12-12
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
Starting date:
December 12,…
AlertHealth professional risk communication | 2020-12-12
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane
Importation of US-labelled Dexrazoxane for Injection distributed by Mylan Pharmaceuticals ULC due to shortage of Canadian-labelled Dexrazoxane…
AlertHealth professional risk communication | 2020-12-01
Unauthorized nicotine buccal pouches may pose serious health risks
Unauthorized nicotine buccal pouches may pose serious health risks
Starting date:
November 2, 2020
Posting…
AlertPublic advisory | 2020-11-02
Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs
Updates to safety labelling for benzodiazepines and benzodiazepine-like drugs
Starting date:
October 30, 2020…
AlertPublic advisory | 2020-10-30
Recalls of Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite
Recalls of Regener-Eyes Ophthalmic Solution and Regener-Eyes Ophthalmic Solution Lite
Starting date:
October 30, 2020…
AlertPublic advisory | 2020-10-30
Testing confirms Bio Life hand sanitizer poses health risks; products recalled across Canada
Testing confirms Bio Life hand sanitizer poses health risks; products recalled across Canada
Starting date:
October 18,…
AlertPublic advisory | 2020-10-28
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer
PICATO (ingenol mebutate gel, 0.015% and 0.05%) - Product Withdrawal in Canada due to Potential Increased Risk of Skin Cancer…
AlertHealth professional risk communication | 2020-10-27
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer
LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer…
AlertInformation update | 2020-10-27